Results: 58
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620953783
- By:
- Publication type:
- Article
Therapeutic interventions for COVID-19: a living overview of reviews.
- Published in:
- 2020
- By:
- Publication type:
- Literature Review
Current situation of asthma–COPD overlap in Chinese patients older than 40 years with airflow limitation: a multicenter, cross-sectional, non-interventional study.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620961699
- By:
- Publication type:
- Article
Early predictors for mechanical ventilation in COVID-19 patients.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620963017
- By:
- Publication type:
- Article
Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620951044
- By:
- Publication type:
- Article
Definition and retrospective application of a clinical scoring system for COVID-19 triage at presentation.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620963019
- By:
- Publication type:
- Article
Derivation and validation of a prediction rule for mortality of patients with respiratory virus-related pneumonia (RV-p score).
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620953780
- By:
- Publication type:
- Article
Respiratory management for patients with neuromuscular disorders during the COVID-19 pandemic.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Worrying situation regarding the use of dexamethasone for COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- Letter
COVID-19 and molecular hydrogen inhalation.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620942417
- By:
- Publication type:
- Article
Helmet CPAP: how an unfamiliar respiratory tool is moving into treatment options during COVID-19 in the US.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620951053
- By:
- Publication type:
- Article
Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620942129
- By:
- Publication type:
- Article
Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620939507
- By:
- Publication type:
- Article
Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620938553
- By:
- Publication type:
- Article
The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- Literature Review
LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- Literature Review
Reclassifying severity after 48 hours could better predict mortality in acute respiratory distress syndrome.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620936877
- By:
- Publication type:
- Article
C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- Literature Review
Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- Literature Review
Predictive value of Chartis measurement for lung function improvements in bronchoscopic lung volume reduction.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620932507
- By:
- Publication type:
- Article
Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620935774
- By:
- Publication type:
- Article
Cytological-energy analysis of pleural effusions with predominance of neutrophils.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620935772
- By:
- Publication type:
- Article
Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620935770
- By:
- Publication type:
- Article
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620926949
- By:
- Publication type:
- Article
Potential specific therapies in COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- Literature Review
Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620915156
- By:
- Publication type:
- Article
Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620933508
- By:
- Publication type:
- Article
Real-life experience with high-frequency chest wall oscillation vest therapy in adults with non-cystic fibrosis bronchiectasis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620932508
- By:
- Publication type:
- Article
The influence of speleotherapy combined with pulmonary rehabilitation on functional fitness in older adults – preliminary report.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620926952
- By:
- Publication type:
- Article
The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620926802
- By:
- Publication type:
- Article
A rare and fatal respiratory disease: bronchial Dieulafoy's disease.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620929236
- By:
- Publication type:
- Article
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620929231
- By:
- Publication type:
- Article
Rapid and precise diagnosis of T. marneffei pulmonary infection in a HIV-negative patient with autosomal-dominant STAT3 mutation: a case report.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620929225
- By:
- Publication type:
- Article
Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO ® clinical trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620926858
- By:
- Publication type:
- Article
Outcome and prognostic factors of interstitial lung disease patients with acute respiratory failure in the intensive care unit.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620926956
- By:
- Publication type:
- Article
Contemporary best practice in the management of pulmonary embolism during pregnancy.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620914222
- By:
- Publication type:
- Article
TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620926800
- By:
- Publication type:
- Article
Association of cathepsin B and cystatin C with an age-related pulmonary subclinical state in a healthy Chinese population.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620921751
- By:
- Publication type:
- Article
RAD52 variants influence NSCLC risk in the Chinese population in a high altitude area.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620918192
- By:
- Publication type:
- Article
Risk factors of non-invasive ventilation failure in hematopoietic stem-cell transplantation patients with acute respiratory distress syndrome.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620914220
- By:
- Publication type:
- Article
Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620916990
- By:
- Publication type:
- Article
Quantitative measurement properties and score interpretation of the Cough Severity Diary in patients with chronic cough.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620915155
- By:
- Publication type:
- Article
Patterns and predictors of low physical activity in patients with stable COPD: a longitudinal study.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620909772
- By:
- Publication type:
- Article
Lymphocyte senescence in COPD is associated with decreased sirtuin 1 expression in steroid resistant pro-inflammatory lymphocytes.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620905280
- By:
- Publication type:
- Article
Optimizing future lung transplant outcomes: asking the right questions for an alternative truth.
- Published in:
- 2020
- By:
- Publication type:
- Letter